Jennifer A Tremmel, MD
Cardiovascular Disease (Cardiology) · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 4 carriers
- Office
- 1
- Since medical school
- 28 years
- University of Iowa, Rj & L Carver College of Medicine, 1998
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
18 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tremmel’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A82309 · Current
Licensed to practise in California · since 2003 · expires 2028-09-30 · University of Iowa College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiovascular Disease
- American Board of Internal Medicine - Interventional Cardiology
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$79,232
Medicare paid this office $79,232 for 403 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 34 | $17,378 | $414 |
| Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | 20 | $12,687 | $529 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 71 | $11,838 | $162 |
| Long return visit (40+ min) | 58 | $7,196 | $118 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 63 | $5,118 | $79 |
See all 12 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 34 | $17,378 | $414 |
| Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | 20 | $12,687 | $529 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 71 | $11,838 | $162 |
| Long return visit (40+ min) | 58 | $7,196 | $118 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 63 | $5,118 | $79 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 14 | $3,234 | $231 |
| Return visit (30+ min) | 37 | $2,746 | $74 |
| Long return visit (40+ min) | 16 | $2,420 | $151 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 31 | $1,863 | $60 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 120 | $1,356 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 150 | $1,111 | $7 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 11 | $750 | $63 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 88 | More than 94% of doctors who do this |
Who their Medicare patients are
403 Original Medicare patients in 2024. Average age 74 · Under 65 9% · 85 and older 13% · Women 47% · Also on Medicaid 26% · Health risk score 1.85. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 69% · Heart failure 39% · Diabetes 38% · Chronic kidney disease 38% · Atrial fibrillation 38% · Depression 24% · COPD 20% · Cancer 18% · Stroke 13% · Dementia 11%.
The office billed $1,044,375, Medicare allowed $102,379 and paid $79,232; for 758 services of 36 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 403 | 758 | 74 | 1.85 | $1,044,375 | $79,232 |
| 2023 | 285 | 625 | 74 | 1.89 | $837,667 | $71,653 |
| 2022 | 273 | 534 | 74 | 2.00 | $625,377 | $59,002 |
| 2021 | 344 | 733 | 73 | 1.82 | $774,965 | $79,126 |
| 2020 | 288 | 552 | 72 | 2.02 | $734,137 | $60,636 |
| 2019 | 419 | 727 | 72 | 1.90 | $607,184 | $68,348 |
| 2018 | 199 | 487 | 70 | 1.89 | $476,646 | $60,318 |
| 2017 | 571 | 964 | 72 | 2.00 | $524,821 | $71,994 |
| 2016 | 244 | 467 | 71 | 1.81 | $463,153 | $67,200 |
| 2015 | 247 | 463 | 71 | 1.77 | $389,711 | $63,356 |
| 2014 | 217 | 426 | 71 | 1.50 | $438,741 | $60,558 |
| 2013 | 225 | 439 | 71 | 1.27 | $316,764 | $49,303 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 28 | $15,965 | $431 |
| Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | 17 | $12,045 | $547 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 58 | $9,519 | $164 |
| Long return visit (40+ min) | 67 | $9,287 | $124 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 55 | $4,555 | $81 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $2,803 | $255 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 23 | $1,436 | $62 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $813 | $45 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 83 | $703 | $7 |
| Return visit (30+ min) | 12 | $528 | $44 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 16 | $383 | $24 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 71 | $365 | $5 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 32 | $352 | $11 |
2022: 9 services
| Long return visit (40+ min) | 98 | $13,482 | $117 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 17 | $9,858 | $448 |
| Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | 14 | $8,461 | $564 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 46 | $7,897 | $168 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 29 | $2,553 | $82 |
| New patient visit (60+ min) | 14 | $2,200 | $157 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 15 | $673 | $29 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 71 | $544 | $7 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 77 | $401 | $5 |
2021: 14 services
| Long return visit (40+ min) | 100 | $17,639 | $126 |
| Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | 24 | $17,001 | $567 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 45 | $8,139 | $181 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 16 | $7,737 | $430 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 16 | $4,122 | $258 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 35 | $3,198 | $82 |
| New patient visit (60+ min) | 18 | $3,180 | $177 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 22 | $1,482 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 124 | $1,172 | $8 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 27 | $1,169 | $30 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 78 | $975 | $11 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $566 | $35 |
| Short return visit | 12 | $402 | $31 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 17 | $93 | $5 |
2020: 12 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 19 | $11,619 | $447 |
| Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | 16 | $11,043 | $581 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 50 | $8,849 | $177 |
| Return visit (30+ min) | 56 | $4,596 | $67 |
| Long return visit (40+ min) | 30 | $3,541 | $101 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 12 | $2,265 | $162 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 24 | $2,139 | $86 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 20 | $1,321 | $66 |
| New patient visit (45+ min) | 11 | $1,231 | $112 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 75 | $931 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 99 | $877 | $8 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 14 | $356 | $25 |
2019: 14 services
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 67 | $11,531 | $165 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 21 | $10,544 | $479 |
| Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | 16 | $10,133 | $563 |
| Return visit (30+ min) | 73 | $6,622 | $68 |
| Biopsy of heart muscle | 16 | $3,059 | $170 |
| Long return visit (40+ min) | 26 | $2,722 | $94 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 14 | $2,344 | $156 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 26 | $2,278 | $84 |
| Insertion of tube in right heart chambers for measurement | 18 | $1,609 | $85 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 193 | $1,542 | $8 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 20 | $1,375 | $69 |
| New patient visit (45+ min) | 11 | $1,283 | $117 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 97 | $1,109 | $11 |
| Short return visit (20+ min) | 19 | $557 | $27 |
2018: 12 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 23 | $11,890 | $457 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 63 | $10,305 | $161 |
| Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | 11 | $7,815 | $558 |
| Biopsy of heart muscle | 17 | $5,480 | $183 |
| Return visit (30+ min) | 54 | $4,078 | $60 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $2,856 | $260 |
| Long return visit (40+ min) | 21 | $1,979 | $94 |
| Short return visit (20+ min) | 39 | $1,708 | $37 |
| Insertion of tube in right heart chambers for measurement | 13 | $1,461 | $64 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 18 | $1,429 | $79 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 87 | $1,054 | $11 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 13 | $1,031 | $79 |
2017: 14 services
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 71 | $12,663 | $173 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 21 | $10,892 | $474 |
| Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | 14 | $7,968 | $569 |
| Biopsy of heart muscle | 21 | $5,594 | $180 |
| Return visit (30+ min) | 62 | $5,483 | $66 |
| Short return visit (20+ min) | 77 | $3,613 | $39 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $3,388 | $261 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 318 | $2,679 | $7 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 11 | $2,306 | $177 |
| Long return visit (40+ min) | 16 | $1,694 | $100 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 21 | $1,653 | $79 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 127 | $1,504 | $11 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 14 | $1,157 | $83 |
| New patient visit (30+ min) | 12 | $792 | $66 |
2016: 10 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 29 | $15,963 | $456 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 77 | $14,825 | $193 |
| Biopsy of heart muscle | 16 | $6,195 | $188 |
| Return visit (30+ min) | 64 | $5,684 | $65 |
| Short return visit (20+ min) | 73 | $4,191 | $40 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 15 | $4,151 | $277 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 15 | $3,334 | $222 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 27 | $2,220 | $82 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 22 | $1,817 | $83 |
| New patient visit (30+ min) | 14 | $882 | $63 |
2015: 10 services
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 71 | $14,260 | $195 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 20 | $12,126 | $466 |
| Short return visit (20+ min) | 99 | $6,441 | $42 |
| Biopsy of heart muscle | 21 | $6,254 | $184 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $3,507 | $270 |
| Return visit (30+ min) | 36 | $3,163 | $70 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 13 | $3,055 | $235 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 24 | $1,999 | $83 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 18 | $1,553 | $82 |
| New patient visit (30+ min) | 14 | $949 | $68 |
2014: 9 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 25 | $16,137 | $475 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 71 | $12,754 | $175 |
| Short return visit (20+ min) | 101 | $7,311 | $40 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 19 | $4,595 | $209 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 16 | $4,390 | $274 |
| Biopsy of heart muscle | 13 | $3,203 | $188 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 23 | $1,989 | $80 |
| New patient visit (30+ min) | 17 | $1,080 | $64 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 11 | $875 | $80 |
2013: 9 services
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 51 | $9,665 | $186 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $8,496 | $472 |
| Short return visit (20+ min) | 101 | $7,564 | $41 |
| Short return visit (20+ min) | 31 | $3,260 | $54 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $2,912 | $265 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 13 | $2,865 | $191 |
| New patient visit (30+ min) | 21 | $1,326 | $63 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 12 | $923 | $77 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 11 | $851 | $77 |
Medicaid work
$1,484 in 2024
Medicaid paid $1,484 for 132 billed services this clinician did in 2024, up to 124 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 132 | $1,484 |
| 2024 | 132 | 1 | 124 | $1,484 |
| 2023 | 51 | 1 | 30 | $323 |
| 2022 | 77 | 1 | 72 | $1,064 |
| 2021 | 126 | 1 | 104 | $1,756 |
| 2020 | 91 | 1 | 46 | $1,079 |
| 2019 | 118 | 1 | 45 | $1,581 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 51 | $323 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 77 | $1,064 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 126 | $1,756 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 91 | $1,079 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 118 | $1,581 |
Drugs they prescribed that Part D paid
$106,371
Pharmacies billed $106,371 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 687) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
593 generic and 94 brand-name prescriptions · $106,371 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Repatha Sureclick | 50 | $52,115 | $1,042 |
| Nebivolol | 17 | $1,630 | $96 |
| Clopidogrel | 77 | $1,149 | $15 |
| Rosuvastatin | 80 | $1,148 | $14 |
| Ezetimibe | 20 | $957 | $48 |
See all 17 drugs
| Repatha Sureclick | 50 | $52,115 | $1,042 |
| Nebivolol | 17 | $1,630 | $96 |
| Clopidogrel | 77 | $1,149 | $15 |
| Rosuvastatin | 80 | $1,148 | $14 |
| Ezetimibe | 20 | $957 | $48 |
| Nitroglycerin | 29 | $821 | $28 |
| Atorvastatin | 85 | $747 | $9 |
| Diltiazem 24hr Er (Cd) | 15 | $703 | $47 |
| Valsartan | 16 | $683 | $43 |
| Metoprolol | 50 | $458 | $9 |
| Losartan | 23 | $328 | $14 |
| Carvedilol | 19 | $310 | $16 |
| Isosorbide Mononitrate Er | 14 | $254 | $18 |
| Lisinopril | 18 | $236 | $13 |
| Amlodipine Besylate | 34 | $220 | $6 |
| Metoprolol | 18 | $176 | $10 |
| Hydrochlorothiazide | 14 | $29 | $2 |
Year by year
| 2024 | 687 | 111 | 0% (0) | 14% | $106,371 |
| 2023 | 725 | 113 | 0% (0) | 13% | $113,338 |
| 2022 | 699 | 113 | 0% (0) | 12% | $109,945 |
| 2021 | 656 | 103 | 0% (0) | 15% | $84,181 |
| 2020 | 742 | 109 | 0% (0) | 12% | $71,579 |
| 2019 | 753 | 112 | 0% (0) | 12% | $86,216 |
| 2018 | 750 | 113 | 0% (0) | 9% | $51,775 |
| 2017 | 1,117 | 128 | 0% (0) | 13% | $68,951 |
| 2016 | 1,220 | 120 | 0% (0) | None | $98,810 |
| 2015 | 1,119 | 135 | 0% (0) | None | $78,617 |
| 2014 | 1,035 | 111 | None | 29% | $77,406 |
| 2013 | 908 | 91 | None | 29% | $56,360 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Repatha Sureclick | 48 | $44,259 | $922 |
| Repatha Pushtronex | 12 | $7,711 | $643 |
| Nebivolol | 19 | $3,967 | $209 |
| Rosuvastatin | 84 | $3,163 | $38 |
| Ezetimibe | 28 | $2,085 | $74 |
| Atorvastatin | 98 | $1,398 | $14 |
| Clopidogrel | 53 | $1,196 | $23 |
| Isosorbide Mononitrate Er | 37 | $1,084 | $29 |
| Valsartan | 13 | $881 | $68 |
| Losartan | 30 | $655 | $22 |
| Nitroglycerin | 21 | $636 | $30 |
| Metoprolol | 33 | $441 | $13 |
| Metoprolol | 26 | $386 | $15 |
| Carvedilol | 15 | $341 | $23 |
| Lisinopril | 31 | $249 | $8 |
| Amlodipine Besylate | 27 | $186 | $7 |
| Hydrochlorothiazide | 19 | $44 | $2 |
| Furosemide | 11 | $42 | $4 |
2022: 20 drugs
| Repatha Sureclick | 19 | $25,567 | $1,346 |
| Repatha Pushtronex | 21 | $17,889 | $852 |
| Ranolazine Er | 13 | $6,331 | $487 |
| Rosuvastatin | 96 | $3,682 | $38 |
| Bystolic | 11 | $1,955 | $178 |
| Atorvastatin | 112 | $1,681 | $15 |
| Ezetimibe | 23 | $976 | $42 |
| Clopidogrel | 49 | $958 | $20 |
| Valsartan | 14 | $941 | $67 |
| Isosorbide Mononitrate Er | 25 | $902 | $36 |
| Nifedipine Er | 11 | $786 | $71 |
| Metoprolol | 39 | $572 | $15 |
| Chlorthalidone | 17 | $394 | $23 |
| Losartan | 24 | $338 | $14 |
| Lisinopril | 26 | $246 | $9 |
| Nitroglycerin | 11 | $241 | $22 |
| Amlodipine Besylate | 20 | $217 | $11 |
| Hydrochlorothiazide | 29 | $161 | $6 |
| Benazepril | 11 | $108 | $10 |
| Metoprolol | 13 | $105 | $8 |
2021: 19 drugs
| Repatha Sureclick | 17 | $18,686 | $1,099 |
| Praluent | 15 | $12,058 | $804 |
| Repatha Pushtronex | 13 | $6,594 | $507 |
| Bystolic | 17 | $5,257 | $309 |
| Ranolazine Er | 17 | $2,730 | $161 |
| Rosuvastatin | 69 | $2,711 | $39 |
| Atorvastatin | 112 | $1,920 | $17 |
| Ezetimibe | 19 | $1,317 | $69 |
| Valsartan | 15 | $1,287 | $86 |
| Clopidogrel | 53 | $1,109 | $21 |
| Isosorbide Mononitrate Er | 23 | $997 | $43 |
| Nitroglycerin | 16 | $844 | $53 |
| Metoprolol | 35 | $780 | $22 |
| Chlorthalidone | 16 | $374 | $23 |
| Losartan | 18 | $273 | $15 |
| Metoprolol | 12 | $244 | $20 |
| Amlodipine Besylate | 26 | $236 | $9 |
| Lisinopril | 17 | $134 | $8 |
| Hydrochlorothiazide | 26 | $103 | $4 |
2020: 16 drugs
| Praluent | 15 | $12,500 | $833 |
| Repatha Sureclick | 12 | $11,319 | $943 |
| Bystolic | 21 | $7,687 | $366 |
| Rosuvastatin | 82 | $3,948 | $48 |
| Atorvastatin | 141 | $2,700 | $19 |
| Nitroglycerin | 22 | $1,506 | $68 |
| Valsartan | 14 | $1,348 | $96 |
| Clopidogrel | 84 | $1,223 | $15 |
| Nifedipine Er | 12 | $1,198 | $100 |
| Isosorbide Mononitrate Er | 36 | $908 | $25 |
| Metoprolol | 26 | $637 | $24 |
| Losartan | 31 | $458 | $15 |
| Amlodipine Besylate | 44 | $272 | $6 |
| Metoprolol | 24 | $243 | $10 |
| Lisinopril | 19 | $218 | $11 |
| Hydrochlorothiazide | 37 | $183 | $5 |
2019: 17 drugs
| Bystolic | 18 | $6,855 | $381 |
| Rosuvastatin | 85 | $5,100 | $60 |
| Atorvastatin | 123 | $2,658 | $22 |
| Isosorbide Mononitrate Er | 41 | $2,254 | $55 |
| Nitroglycerin | 21 | $1,665 | $79 |
| Clopidogrel | 74 | $1,291 | $17 |
| Nifedipine Er | 15 | $1,227 | $82 |
| Ezetimibe | 17 | $1,162 | $68 |
| Metoprolol | 19 | $881 | $46 |
| Valsartan | 12 | $858 | $71 |
| Nitroglycerin Patch | 12 | $830 | $69 |
| Losartan | 36 | $658 | $18 |
| Potassium Chloride | 13 | $622 | $48 |
| Amlodipine Besylate | 44 | $315 | $7 |
| Carvedilol | 12 | $226 | $19 |
| Hydrochlorothiazide | 36 | $220 | $6 |
| Metoprolol | 26 | $163 | $6 |
2018: 19 drugs
| Rosuvastatin | 83 | $4,687 | $56 |
| Atorvastatin | 148 | $3,940 | $27 |
| Bystolic | 15 | $3,914 | $261 |
| Ezetimibe | 14 | $1,998 | $143 |
| Clopidogrel | 84 | $1,743 | $21 |
| Isosorbide Mononitrate Er | 35 | $1,524 | $44 |
| Valsartan | 16 | $1,141 | $71 |
| Metoprolol | 25 | $1,034 | $41 |
| Nifedipine Er | 13 | $1,008 | $78 |
| Nitroglycerin Patch | 13 | $645 | $50 |
| Potassium Chloride | 11 | $534 | $49 |
| Losartan | 26 | $442 | $17 |
| Carvedilol | 25 | $399 | $16 |
| Nitroglycerin | 17 | $382 | $22 |
| Simvastatin | 13 | $337 | $26 |
| Hydrochlorothiazide | 41 | $263 | $6 |
| Amlodipine Besylate | 21 | $237 | $11 |
| Metoprolol | 29 | $197 | $7 |
| Lisinopril | 11 | $88 | $8 |
2017: 23 drugs
| Brilinta | 17 | $9,432 | $555 |
| Rosuvastatin | 114 | $8,204 | $72 |
| Atorvastatin | 189 | $4,128 | $22 |
| Valsartan | 29 | $3,413 | $118 |
| Metoprolol | 56 | $2,265 | $40 |
| Clopidogrel | 123 | $1,945 | $16 |
| Bystolic | 12 | $1,881 | $157 |
| Isosorbide Mononitrate Er | 57 | $1,519 | $27 |
| Nitroglycerin | 15 | $857 | $57 |
| Potassium Chloride | 19 | $803 | $42 |
| Nitroglycerin Patch | 20 | $581 | $29 |
| Nitrostat | 14 | $541 | $39 |
| Carvedilol | 47 | $413 | $9 |
| Amlodipine Besylate | 34 | $413 | $12 |
| Hydrochlorothiazide | 69 | $326 | $5 |
| Metoprolol | 35 | $284 | $8 |
| Losartan | 26 | $269 | $10 |
| Pravastatin | 16 | $251 | $16 |
| Lisinopril | 27 | $211 | $8 |
| Irbesartan | 13 | $171 | $13 |
| Simvastatin | 16 | $150 | $9 |
| Furosemide | 19 | $138 | $7 |
| Spironolactone | 14 | $119 | $8 |
2016: 24 drugs
| Crestor | 86 | $30,357 | $353 |
| Ranexa | 19 | $9,487 | $499 |
| Atorvastatin | 218 | $3,938 | $18 |
| Zetia | 13 | $3,576 | $275 |
| Rosuvastatin | 33 | $3,351 | $102 |
| Valsartan | 29 | $3,134 | $108 |
| Isosorbide Mononitrate Er | 85 | $2,770 | $33 |
| Bystolic | 20 | $2,166 | $108 |
| Clopidogrel | 103 | $2,025 | $20 |
| Metoprolol | 32 | $1,426 | $45 |
| Nitrostat | 28 | $995 | $36 |
| Nifedipine Er | 13 | $821 | $63 |
| Potassium Chloride | 21 | $810 | $39 |
| Carvedilol | 38 | $574 | $15 |
| Losartan | 43 | $474 | $11 |
| Nitroglycerin Patch | 15 | $407 | $27 |
| Amlodipine Besylate | 48 | $390 | $8 |
| Hydrochlorothiazide | 70 | $283 | $4 |
| Simvastatin | 21 | $266 | $13 |
| Lisinopril | 26 | $253 | $10 |
| Metoprolol | 35 | $231 | $7 |
| Candesartan Cilexetil | 11 | $195 | $18 |
| Irbesartan | 11 | $94 | $9 |
| Lovastatin | 11 | $87 | $8 |
2015: 21 drugs
| Crestor | 72 | $27,163 | $377 |
| Ranexa | 19 | $9,168 | $483 |
| Atorvastatin | 221 | $3,808 | $17 |
| Metoprolol | 46 | $2,282 | $50 |
| Valsartan | 18 | $2,115 | $117 |
| Isosorbide Mononitrate Er | 75 | $1,949 | $26 |
| Candesartan Cilexetil | 17 | $1,911 | $112 |
| Bystolic | 12 | $1,498 | $125 |
| Clopidogrel | 116 | $1,183 | $10 |
| Potassium Chloride | 14 | $765 | $55 |
| Losartan | 56 | $732 | $13 |
| Nitrostat | 30 | $619 | $21 |
| Pravastatin | 11 | $617 | $56 |
| Carvedilol | 34 | $507 | $15 |
| Hydrochlorothiazide | 46 | $330 | $7 |
| Lisinopril | 34 | $284 | $8 |
| Amlodipine Besylate | 35 | $245 | $7 |
| Metoprolol | 43 | $205 | $5 |
| Simvastatin | 27 | $199 | $7 |
| Lovastatin | 15 | $123 | $8 |
| Furosemide | 11 | $42 | $4 |
2014: 20 drugs
| Crestor | 51 | $17,801 | $349 |
| Ranexa | 23 | $10,134 | $441 |
| Diovan | 25 | $4,827 | $193 |
| Atorvastatin | 170 | $3,821 | $22 |
| Clopidogrel | 95 | $2,481 | $26 |
| Metoprolol | 52 | $2,110 | $41 |
| Bystolic | 18 | $1,797 | $100 |
| Isosorbide Mononitrate Er | 51 | $1,462 | $29 |
| Carvedilol | 57 | $798 | $14 |
| Losartan | 47 | $796 | $17 |
| Nitrostat | 28 | $523 | $19 |
| Pravastatin | 13 | $487 | $37 |
| Hydrochlorothiazide | 34 | $400 | $12 |
| Potassium Chloride | 19 | $381 | $20 |
| Amlodipine Besylate | 38 | $365 | $10 |
| Lisinopril | 39 | $312 | $8 |
| Simvastatin | 32 | $264 | $8 |
| Lovastatin | 21 | $245 | $12 |
| Metoprolol | 33 | $235 | $7 |
| Furosemide | 14 | $44 | $3 |
2013: 21 drugs
| Crestor | 23 | $8,749 | $380 |
| Clopidogrel | 112 | $5,445 | $49 |
| Diovan | 26 | $4,568 | $176 |
| Niaspan | 16 | $3,534 | $221 |
| Atorvastatin | 102 | $3,178 | $31 |
| Bystolic | 29 | $2,913 | $100 |
| Metoprolol | 28 | $2,243 | $80 |
| Isosorbide Mononitrate Er | 37 | $1,373 | $37 |
| Losartan | 23 | $791 | $34 |
| Carvedilol | 44 | $665 | $15 |
| Simvastatin | 61 | $578 | $9 |
| Amlodipine Besylate | 51 | $420 | $8 |
| Nitrostat | 26 | $329 | $13 |
| Lisinopril | 52 | $312 | $6 |
| Losartan-Hydrochlorothiazide | 18 | $296 | $16 |
| Triamterene-Hctz | 16 | $281 | $18 |
| Metoprolol | 33 | $260 | $8 |
| Hydrochlorothiazide | 29 | $245 | $8 |
| Enalapril Maleate | 17 | $222 | $13 |
| Warfarin | 12 | $79 | $7 |
| Atenolol | 13 | $66 | $5 |
Money from drug and device companies
$73,949 in 2025
| 2025 | 4 | 34 | $66,138 | $73,949 |
| 2024 | 5 | 40 | $42,646 | $47,575 |
| 2023 | 3 | 11 | $23,150 | $23,381 |
| 2022 | 4 | 12 | $22,450 | $23,450 |
| 2021 | 3 | 13 | $25,163 | $25,237 |
| 2020 | 2 | 3 | None | $117 |
| 2019 | 5 | 50 | $23,098 | $39,638 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Coroflow | $45,961 | 14 payments
|
| Boston Scientific | General - Vascular Access | $21,306 | 15 payments
|
| Edwards Lifesciences | None | $3,750 | 2 payments
|
| Cordis US | None | $2,932 | 3 payments
|
See all 34 published payments
| Edwards Lifesciences | Consulting · 2025-12-23 | None | $900 |
| Cordis US | Travel · 2025-12-16 | None | $799 |
| Cordis US | Travel · 2025-12-10 | None | $915 |
| Cordis US | Travel · 2025-12-02 | None | $1,219 |
| Abbott Laboratories | Consulting · 2025-10-31 | Pressurewire | $3,000 |
| Abbott Laboratories | Meals · 2025-10-27 | Coroflow | $25 |
| Abbott Laboratories | Meals · 2025-10-27 | Coroflow | $115 |
| Abbott Laboratories | Consulting · 2025-10-23 | Optis | $1,200 |
| Edwards Lifesciences | Consulting · 2025-07-31 | None | $2,850 |
| Abbott Laboratories | Consulting · 2025-07-08 | Coroflow | $23,100 |
| Abbott Laboratories | Meals · 2025-07-08 | Pressurewire | $173 |
| Abbott Laboratories | Travel · 2025-07-08 | Coroflow | $468 |
| Boston Scientific | Paid to speak or teach · 2025-07-03 | General - Vascular Access | $5,000 |
| Abbott Laboratories | Consulting · 2025-06-30 | Pressurewire | $3,600 |
| Abbott Laboratories | Consulting · 2025-06-30 | Pressurewire | $3,900 |
| Boston Scientific | Meals · 2025-06-17 | General - Balloon Catheters | $144 |
| Boston Scientific | Travel · 2025-06-17 | General - Vascular Access | $1,141 |
| Abbott Laboratories | Travel · 2025-06-03 | Pressurewire | $1,185 |
| Abbott Laboratories | Travel · 2025-06-03 | Pressurewire | $9 |
| Boston Scientific | Consulting · 2025-05-29 | General - Balloons | $5,313 |
| Boston Scientific | Consulting · 2025-05-29 | General - Balloons | $625 |
| Boston Scientific | Travel · 2025-05-29 | General - Balloons | $95 |
| Abbott Laboratories | Consulting · 2025-05-27 | Optis | $3,000 |
| Abbott Laboratories | Meals · 2025-05-15 | Pressurewire | $35 |
| Boston Scientific | Meals · 2025-04-05 | Avvigo Guidance System | $219 |
| Boston Scientific | Travel · 2025-04-04 | Avvigo Guidance System | $540 |
| Boston Scientific | Travel · 2025-04-04 | Avvigo Guidance System | $240 |
| Boston Scientific | Meals · 2025-04-04 | Avvigo Guidance System | $231 |
| Boston Scientific | Paid to speak or teach · 2025-04-03 | General - Vascular Access | $2,500 |
| Boston Scientific | Meals · 2025-04-03 | Avvigo Guidance System | $33 |
| Abbott Laboratories | Consulting · 2025-03-06 | Optis | $6,150 |
| Boston Scientific | Meals · 2025-02-28 | General - Therapies | $74 |
| Boston Scientific | Paid to speak or teach · 2025-01-30 | General - Vascular Access | $5,000 |
| Boston Scientific | Meals · 2025-01-21 | General - Balloon Catheters | $149 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $47,575
| Boston Scientific | None | $18,650 | 21 payments
|
| Abbott Laboratories | Optis | $11,467 | 4 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $8,764 | 8 payments
|
| Cordis US | Cardio | $8,607 | 6 payments
|
| Seigla Medical | None | $86 | 1 payment
|
2023: $23,381
| Abbott Laboratories | Optis | $17,700 | 2 payments
|
| Boston Scientific | Synergy | $3,481 | 8 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $2,200 | 1 payment
|
2022: $23,450
| Abbott Laboratories | Xience Sierra | $20,198 | 4 payments
|
| Boston Scientific | General - Vascular Access | $2,856 | 6 payments
|
| CathWorks | Ffrangio | $261 | 1 payment
|
| Medtronic | Resolute Onyx | $136 | 1 payment
|
2021: $25,237
| Abbott Laboratories | Dragonfly Oct | $21,224 | 10 payments
|
| Boston Scientific | General Vascular Access | $3,563 | 2 payments
|
| Terumo Medical | None | $450 | 1 payment
|
2020: $117
| Boston Scientific | General - Vascular Access | $101 | 2 payments
|
| Abbott Laboratories | Xience Sierra Coronary Stent | $16 | 1 payment
|
2019: $39,638
| Terumo Medical | Optitorque | $16,901 | 13 payments
|
| Philips Electronics North America | Igt Systems Und | $13,404 | 6 payments
|
| Boston Scientific | General Therapies | $9,054 | 21 payments
|
| Abbott Laboratories | Cardiovascular- Research Only | $161 | 9 payments
|
| Abiomed | Impella | $119 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Shockwave Medical, Inc · Equity in Modifying Plaque of Women With Undertreated Calcified Coronary Artery Disease · 2025 | Their institution | $340,918 |
| Boston Scientific Corporation · Agent Ide · 2023 | Their institution | $109,082 |
| BOSTON SCIENTIFIC CORPORATION · Agent Ide · 2022 | Their institution | $54,433 |
| Boston Scientific Corporation · Agent Ide · 2025 | Their institution | $34,384 |
| Medtronic, Inc. · Prevail Global · 2025 | Their institution | $24,141 |
| Shockwave Medical, Inc · Empower Cad · 2024 | Their institution | $23,419 |
| Boston Scientific Corporation · Agent Ide · 2024 | Their institution | $14,920 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1093733909
- Licence
- CA A82309California A82309: Current · expires 2028-09-30
- Trained
- University of Iowa, Rj & L Carver College of Medicine, 1998 · 28 years ago
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X); Cardiology (207RC0000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-07-18
- NPI last updated
- 2024-04-26
- NPI record certified
- 2024-04-26
This is when the NPI record was last certified, not a medical board exam.